RUBIS/ FR0013269123 /
| - - | Chg. - | Volume | Bid20:30:00 | Ask20:30:00 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 25.300EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 2.61 bill.EUR | - | 7.38 |
GlobeNewswire
08/11/2023
Hemper and 40 Tons Launch Rolling Tray Collab to Raise Awareness for Incarcerated Individuals
Newsfile Corp
04/10/2023
The New Immersive Exhibition, A Portal for Healing, Opening at theART-Dept. In West Hollywood Octobe...
GlobeNewswire
21/05/2021
Athenex Announces Klisyri® (tirbanibulin) Receives Positive CHMP Opinion from the European Medicines...
GlobeNewswire
17/05/2021
Athenex, Texas Children’s Cancer Center, and the Center for Cell and Gene Therapy at Baylor College ...
GlobeNewswire
04/05/2021
Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineere...
GlobeNewswire
27/04/2021
Athenex to Provide Corporate and Financial Update for the First Quarter 2021 on May 6, 2021
GlobeNewswire
01/03/2021
Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update
GlobeNewswire
01/03/2021
Athenex Receives FDA Complete Response Letter for Oral Paclitaxel Plus Encequidar for the Treatment ...
GlobeNewswire
22/02/2021
Athenex to Provide a Corporate and Financial Update for the Fourth Quarter and Full Year 2020 on Mar...
GlobeNewswire
18/02/2021
Athenex Announces U.S. Launch of Klisyri® and Licensing of Additional Territories for Tirbanibulin
GlobeNewswire
11/02/2021
Athenex Announces New England Journal of Medicine Publication of Phase III Data on the Efficacy and ...
GlobeNewswire
15/12/2020
Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on ...
GlobeNewswire
09/12/2020
Athenex Presents Updated Phase 3 Data on Survival and Tolerability Associated with Oral Paclitaxel a...
GlobeNewswire
02/12/2020
Athenex Pharmaceutical Division and Ingenus Pharmaceuticals Announce Availability of Liquid, Ready t...
GlobeNewswire
17/11/2020
Athenex Announces Data on Oral Paclitaxel and Encequidar to be Presented at the 2020 San Antonio Bre...
GlobeNewswire
05/11/2020
Athenex, Inc. Reports Third Quarter Ended September 30, 2020 Financial Results and Provides Corporat...
GlobeNewswire
22/10/2020
Athenex, Inc. to Report Third Quarter 2020 Earnings Results on November 5, 2020
GlobeNewswire
12/10/2020
Axis Therapeutics Announces Research Collaboration with PharmaEssentia for Development of TCR-T Cell...
